 |
30 Diseases |  |
8 Trials |
|
8 Trials |  |
318 News |  |
| «123456 |
- ||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New trial: CREGS-S: Cerebrolysin REGistry Study in Stroke (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=2000, Recruiting, Sponsor: Ever Neuro Pharma GmbH
- ||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Enrollment closed, Trial primary completion date: The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery (clinicaltrials.gov) - Feb 10, 2015
P4, N=800, Active, not recruiting, Sponsor: Ever Neuro Pharma GmbH
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jun 2015
- | Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P1/2 trial: Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke (clinicaltrials.gov) - May 27, 2014
P1/2, N=60, Completed, Sponsor: Shanghai 6th People's Hospital
- | Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P2 trial, HEOR: Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy (clinicaltrials.gov) - Apr 14, 2014
P2, N=100, Recruiting, Sponsor: Ain Shams University
- ||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Trial initiation date: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) (clinicaltrials.gov) - Apr 2, 2014
P4, N=510, Not yet recruiting, Sponsor: Ever Neuro Pharma GmbH
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Jun 2015 Initiation date: Sep 2013 --> Jul 2014
- | Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P4 trial: E-COMPASS: Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke (clinicaltrials.gov) - Nov 25, 2013
P4, N=75, Recruiting, Sponsor: Samsung Medical Center
- ||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Trial initiation date: The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery (clinicaltrials.gov) - Sep 23, 2013
P4, N=800, Recruiting, Sponsor: Ever Neuro Pharma GmbH
Initiation date: Sep 2013 --> Jul 2014 Initiation date: May 2013 --> Sep 2013
- |||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Enrollment open: The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery (clinicaltrials.gov) - Sep 23, 2013
P4, N=800, Recruiting, Sponsor: Ever Neuro Pharma GmbH
Initiation date: May 2013 --> Sep 2013 Not yet recruiting --> Recruiting
- Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Trial completion: CerebroHIE: Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy (clinicaltrials.gov) - Sep 11, 2013
P2, N=40, Completed, Sponsor: Sahar M.A. Hassanein, MD
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P4 trial: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) (clinicaltrials.gov) - Apr 2, 2013
P4, N=510, Not yet recruiting, Sponsor: Ever Neuro Pharma GmbH
- Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P2/3 trial: CESAR: Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin (clinicaltrials.gov) - Feb 6, 2013
P2/3, N=50, Not yet recruiting, Sponsor: Kwong Wah Hospital
- Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Trial initiation date: CerebroHIE: Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy (clinicaltrials.gov) - Sep 4, 2012
P2, N=40, Completed, Sponsor: Sahar M.A. Hassanein, MD
Recruiting --> Completed Initiation date: Mar 2010 --> Mar 2011
- ||||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P4 trial: The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery (clinicaltrials.gov) - May 23, 2012
P4, N=800, Recruiting, Sponsor: Ever Neuro Pharma GmbH
- Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
Trial completion: CIB-NBS-C: Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. (clinicaltrials.gov) - Nov 6, 2011
P3, N=30, Completed, Sponsor: Clinical Institute of the Brain, Russia
Initiation date: Mar 2010 --> Mar 2011 Recruiting --> Completed